EVP, Innovative Medicine, R&D
Avg Cost/Share
$192.71
Shares
21,721
Total Value
$4,185,793.09
Owned After
10,658
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| REED JOHN C | JNJ | EVP, Innovative Medicine, R&D | Oct 17, 2025 | Sell | $192.71 | 21,721 | $4,185,793.09 | 10,658 |